 |
|
 |
|
| News |  |
|
|
| Firmen | |
|
|
| Industrieinformationen | |
|
|
| Journale | |
|
|
| Bücher | |
|
|
| Events | |
|
|
| Hotlinks | |
|
|
| Newsletter abonnieren | |
|
|
| Impressum | |
|
|
|
|
|
Edwards Life Sciences GmbH
Edisonstr. 6 85716 Unterschleißheim Tel.: 089/95475-0 Fax: 089/95475-400
Edwards Lifesciences (NYSE: EW) is a global leader in products and technologies to treat advanced cardiovascular disease and the number-one heart valve company in the world. Headquartered in Irvine, California, we focus on four main cardiovascular disease states: heart valve disease, coronary artery disease, peripheral vascular disease and congestive heart failure. We leverage our design, development and marketing expertise through our main product categories: Cardiac Surgery, Critical Care, Vascular and Perfusion. Our global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, Duraflo, Fogarty, Research Medical, Starr-Edwards and Swan-Ganz. Working as trusted partners in the community fighting cardiovascular disease, we are committed to helping patients and improving the quality of life around the world. Our company's Credo contains the pledge, "Helping Patients is Our Life's Work, and Life is Now."
[zurück] |
|
|
